本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BridgeBio Pharma, Inc.

43.99
+1.162.71%
盘后44.000.0100+0.02%16:20 EDT
成交量:245.97万
成交额:1.07亿
市值:83.53亿
市盈率:-12.44
高:44.07
开:42.63
低:42.29
收:42.83
数据加载中...
2025/07/02

重要事件披露

Form 8-K - Current report
2025/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/23

重要事件披露

Form 8-K - Current report
2025/06/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/29

重要事件披露

Form 8-K - Current report
2025/04/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/17

重要事件披露

Form 8-K - Current report
2025/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities